Drug Discovery & Development
Could a MERS vaccine candidate be the answer for COVID-19?
As researchers urgently work to develop vaccines, many strategies have been considered. Now, a parainfluenza virus 5-based vaccine expressing MERS-CoV spike protein may provide an avenue for a COVID-19 vaccine based on the similarity of the two viruses, according to a study published in mBio on April 7.  Discuss
Arrakis Therapeutics partners with Roche
Biopharmaceutical firm Arrakis Therapeutics has inked a license agreement with Roche to collaborate on research of Roche's RNA-targeted small-molecule drugs.
COVID-19 shuts down research labs as concern grows among scientists
Almost half of all scientific research labs that participated in a recent survey were shut down due to concerns about the COVID-19 outbreak. Survey results indicate that scientists are quite concerned and that their work is considerably impacted by the pandemic, according to a new COVID-19 scientist sentiment tracker.  Discuss
SARS-CoV-2 vaccine utilizing microneedle arrays appears in the literature
Within four weeks of the SARS-CoV-2 spike sequence becoming available, researchers from the University of Pittsburgh School of Medicine developed immunogens for a potential COVID-19 vaccine. The vaccine is delivered through a fingertip-sized patch, and it produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus, according to the April 2 EBioMedicine publication.  Discuss
Funding floodgates open for COVID-19 research
The impacts of the COVID-19 pandemic are being felt around the world. Researchers are working at a record-setting pace to understand the novel coronavirus and develop and test therapies. As seen by recent funding announcements, mitigating the economic effects of this crisis is a top priority for the global community.  Discuss
How AI is speeding development of COVID-19 therapies
As the world is facing a new challenge in trying to both adapt to and defend itself against the novel coronavirus, artificial intelligence (AI) is offering new hope that a cure might be developed faster than ever before. Ulrik Kristensen, PhD, from Signify Research offers a perspective.  Discuss
Researchers bait viruses with chemically designed structures
A new therapeutic approach for suppressing seasonal influenza that involves synthetic phage shells that interfere with pathogen adhesion is immediately being tested for use on coronaviruses in response to the global COVID-19 pandemic. The research findings were published in Nature Nanotechnology on March 30.  Discuss
Researchers reveal vulnerabilities of 'addicted' cancer cells
New findings about the mechanism by which some cancer cells can become "addicted" to glucose could lead to fresh approaches to targeted cancer therapies. The results of the research were published in Nature Cell Biology on March 30.  Discuss
Controversy hits Gilead over orphan status for COVID-19 drug
Gilead Sciences has rescinded its request for orphan drug status for an experimental drug for treating COVID-19 just two days after getting approval from the U.S. Food and Drug Administration. The company had been hit with criticism that the approval would block other COVID-19 drugs from reaching the market.  Discuss
Researchers explore mutations to improve drug design
Drug resistance is a common challenge when designing therapeutics for cancers or diseases originating from bacteria or viruses. Researchers explored how evolution impacted the mutation of these pathogens, and their findings could lead to the development of evolutionarily designed drugs. The results were published March 24 in Cell Reports.  Discuss
Conferences
BioProcess International Europe
April 28 - May 1
Amsterdam, Noord-Holland Netherlands
Lab of the Future USA
May 19-20
Boston, Massachusetts United States
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International
September 21-24
Boston, Massachusetts United States
General Discussion
Topic Replies / Views Last Update
Open science for the modern scientific community
by LMoraes
3 / 53 More than 3 days ago
by The Mets
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 14 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 8 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter